Transient Removal of CD46 Is Safe and Increases B-Cell Depletion by Rituximab in CD46 Transgenic Mice and Macaques
Molecular Therapy - United States
doi 10.1038/mt.2012.212
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Elsevier BV